The Next Frontier: The Oral Small Molecule GLP-1s While injectable peptides like semaglutide and tirzepatide have revolutionized treatment, they are not the endgame
GLP-1 medications are recommended in the ADA Standards of Care for those with cardiovascular disease, heart failure, and/or kidney disease to reduce the risk of adverse events due to these conditions
Our team ensures safe prescribing and personalized support from start to finish
Others struggle with nausea, vomiting, or stomach discomfort that makes the treatment hard to continue
quick-service spending down about 8 percent
Future studies will investigate the effect of MariTide on cardiovascular disease, heart failure, chronic kidney disease, and obstructive sleep apnea